Basic Science Neuropathology

Neurodegenerative

Neurodegenerative Neuropathology

What You'll Learn

  • To classify neurodegeneration by the misfolded protein — tau, α-synuclein, TDP-43, polyQ, prion
  • The signature inclusion, stain, and regional atrophy for each disease
  • How to separate the overlapping dementias and parkinsonisms on tissue

The neuropathology view — inclusions, stains, distribution. Clinical diagnosis/treatment lives in the Dementia and Movement Disorders notes.

🔍 High-Yield Pearls
  • Alzheimer: extracellular neuritic (Aβ) plaques + intracellular neurofibrillary tangles (tau); plaques shown with Bielschowsky/silver, thioflavin-S, Aβ IHC (Congo red highlights amyloid cores & CAA). Tangle spread follows Braak staging.
  • Synucleinopathies: PD = nigral Lewy bodies; DLB requires limbic/cortical Lewy bodies; MSA = oligodendroglial cytoplasmic inclusions (Papp-Lantos). All α-synuclein+.
  • ALS / FTLD-TDP: ubiquitin+, TDP-43+ cytoplasmic inclusions; ALS shows motor-neuron loss + Bunina bodies + corticospinal-tract degeneration.
  • Huntington: caudate (medium spiny neuron) atrophy → “box-car” frontal horns; intranuclear huntingtin/ubiquitin inclusions.
  • Prion (CJD): spongiform vacuolation + neuronal loss + gliosis, no inflammation; PrPSc immunostain.
Alzheimer Disease & Tauopathies
DiseasePathologyStain / distribution
AlzheimerNeuritic Aβ plaques + neurofibrillary tangles (paired helical tau); neuropil threads; granulovacuolar degeneration & Hirano bodies (hippocampus); CAABielschowsky/thioflavin/Aβ IHC; tau IHC; Braak tangle + Thal amyloid staging; hippocampal & temporoparietal atrophy
PSPGlobose tangles, tufted astrocytes, coiled bodies; midbrain/pallidum/subthalamic4R-tau; midbrain atrophy (“hummingbird”)
Corticobasal degenerationAstrocytic plaques, ballooned achromatic neurons; asymmetric frontoparietal4R-tau
Pick disease (FTLD-tau)Pick bodies (round argyrophilic), ballooned Pick cells; knife-edge frontotemporal atrophy3R-tau; silver+
Synucleinopathies
DiseasePathologyClue
Parkinson diseaseNigral Lewy bodies (eosinophilic, halo) & Lewy neurites; loss of pigmented dopaminergic neuronsDepigmented substantia nigra; α-synuclein+; Braak PD staging (ascending)
Dementia with Lewy bodiesLimbic + neocortical Lewy bodies/neurites (cortical LBs less distinct)α-synuclein IHC required to see cortical LBs
Multiple system atrophyGlial cytoplasmic inclusions (Papp-Lantos bodies) in oligodendrocytes; striatonigral & olivopontocerebellar degenerationα-synuclein+; putaminal/pontine (“hot cross bun”) atrophy
TDP-43 Proteinopathies & Motor Neuron Disease
DiseasePathologyInclusion
ALSLoss of anterior-horn & upper motor neurons; corticospinal tract degeneration; neurogenic muscle atrophyCytoplasmic TDP-43 skein-like / ubiquitin inclusions; Bunina bodies (cystatin C+, eosinophilic)
FTLD-TDPFrontotemporal neuronal loss, superficial spongiosisTDP-43+ cytoplasmic inclusions (ubiquitin+, tau-negative)

C9orf72 hexanucleotide expansion links familial ALS & FTLD and adds p62+/TDP-43-negative inclusions.

Polyglutamine & Prion Disease
DiseasePathologySignature
HuntingtonAtrophy of caudate > putamen (medium spiny neuron loss) → ex-vacuo “box-car” frontal hornsIntranuclear huntingtin/ubiquitin inclusions; CAG expansion
Creutzfeldt-Jakob (prion)Spongiform vacuolation, neuronal loss, astrogliosis, no inflammatory infiltratePrPSc IHC (protease-resistant); vCJD shows florid kuru plaques
Friedreich ataxiaDegeneration of dorsal columns, spinocerebellar & corticospinal tracts, dorsal root gangliaGAA expansion (frataxin)
High-Yield Facts
Inclusion / findingProteinDisease
Neurofibrillary tangles + Aβ plaquesTau + AβAlzheimer
Tufted astrocytes4R-tauPSP
Astrocytic plaques4R-tauCBD
Pick bodies3R-tauPick disease
Lewy bodyα-synucleinPD / DLB
Glial cytoplasmic inclusions (Papp-Lantos)α-synucleinMSA
Skein-like inclusions (TDP-43) + Bunina bodies (cystatin C)TDP-43 / cystatin CALS
Spongiform change, no inflammationPrPScCJD
References
  • Love S, et al. Greenfield's Neuropathology. 9th ed. 2015.
  • Kovacs GG. Molecular pathological classification of neurodegenerative diseases. Int J Mol Sci. 2016.
🔒

Continue reading — sign in

The full note has more clinical pearls, tables, and board-focused tips. Free account, no fee.